SEC Form 4 · accession 0001209191-15-021260
CELGENE CORP /DE/ · CELG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Perry A Karsen
Officer — see remarks
Period of report
Mar 1, 2015
Accepted (ET)
Mar 3, 2015 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816284
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2015 | M | 8,334 | $0.00 | A | 78,451 | D | |
| Common Stock | Mar 1, 2015 | F | 4,321 | $121.53 | D | 74,130 | D | |
| Common Stock | holding | — | — | — | 2,000 | I | IRA Account | |
| Common Stock | holding | — | — | — | 1,639 | I | 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F1,F2 | — | Mar 1, 2015 | M | 8,334 | D | — | — | Common Stock | 8,334 | 0 | D |
Explanation of responses
- F1All of the restricted stock units granted to the reporting person on March 1, 2012 vested and settled for shares of the Company's common stock.
- F2Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- F3The restricted stock units were issued pursuant to The Celgene Corporation 2008 Stock Incentive Plan (as Amended and Restated as of April 17, 2013).
Remarks
Chief Executive Officer, Celgene Cellular Therapuetics